Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Arrowhead Pharmaceuticals Inc. buy Royal Bank of Canada

Arrowhead Pharmaceuticals Inc.
Start price
€17.89
11.02.25 / 50%
Target price
€40.58
11.02.26
Performance (%)
193.80%
End price
€52.56
12.02.26
Summary
This prediction ended on 12.02.26 with a price of €52.56. The BUY prediction by Royal_Bank_of_Canada for Arrowhead Pharmaceuticals Inc. saw massive gains of 193.80%. Royal_Bank_of_Canada has a follow-up prediction for Arrowhead Pharmaceuticals Inc. where he still thinks Arrowhead Pharmaceuticals Inc. is a Buy. Royal_Bank_of_Canada has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Arrowhead Pharmaceuticals Inc. 11.738% 11.738% 360.807%
iShares Core DAX® 0.751% -8.496% 2.575%
iShares Nasdaq 100 -1.405% -2.771% 15.682%
iShares Nikkei 225® 0.417% -9.291% 29.655%
iShares S&P 500 -0.590% -2.868% 9.963%

Comments by Royal_Bank_of_Canada for this prediction

In the thread Arrowhead Pharmaceuticals Inc. diskutieren
Prediction Buy
Perf. (%) 193.80%
Target price 40.580
Change
Ends at 11.02.26

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $42.00 price target on the stock.
Ratings data for ARWR provided by MarketBeat

Royal Bank of Canada 
0
Report Share
11.02.25
In the thread Trading Arrowhead Pharmaceuticals Inc.
Prediction Buy
Perf. (%) 193.80%
Target price 40.580
Change
Ends at 11.02.26

Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten

Royal Bank of Canada 
0
Report Share
12.02.26

Current prediction by Royal_Bank_of_Canada for Arrowhead Pharmaceuticals Inc.

buy
Arrowhead Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€14.10
08.08.25
€32.59
08.08.26
284.82%
31.03.26

Royal Bank of Canada 
08.08.25 50%

Stopped prediction by Royal_Bank_of_Canada for Arrowhead Pharmaceuticals Inc.

buy
Arrowhead Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€60.18
11.12.25
€68.44
11.12.26
-9.84%
31.03.26

Royal Bank of Canada 
11.12.25 50%
buy
Arrowhead Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€34.14
19.11.25
€44.92
19.11.26
58.93%
31.03.26

Royal Bank of Canada 
19.11.25 50%
buy
Arrowhead Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€17.62
26.09.24
€37.69
26.09.25
58.05%
27.09.25

Royal Bank of Canada 
26.09.24 50%
buy
Arrowhead Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€29.40
07.02.24
€46.44
07.02.25
-32.70%
08.02.25

Royal Bank of Canada 
07.02.24 50%
buy
Arrowhead Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€31.94
16.01.24
€45.92
16.01.25
-41.56%
17.01.25

Royal Bank of Canada 
16.01.24 50%
buy
Arrowhead Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€22.00
30.11.23
€45.85
30.11.24
11.32%
01.12.24

Royal Bank of Canada 
30.11.23 50%
buy
Arrowhead Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€25.07
08.08.23
€54.74
08.08.24
-10.25%
09.08.24

Royal Bank of Canada 
08.08.23 50%